Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK-803

Known as: MK 803, MK803 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
SummaryLovastatin (MK-803, mevinolin) and simvastatin (MK-733, synvinolin), 2 highly potent 3-hydroxy-3-methylglutaryl coenzyme A… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The present study corroborates previous findings showing that the selective, non-competitive N-methyl-D-aspartate (NMDA… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1993
1993
The possible difference between lovastatin (mevinolin, MK-803), simvastatin (MK-733) and pravastatin (CS-514), all chemically… Expand
Is this relevant?
1989
1989
Relatively high concentrations of MK-733 (simvastatin) and MK-803 (lovastatin, mevinolin), which are 3-hydroxy-3-methylglutaryl… Expand
Is this relevant?
1988
1988
The preventive effect of MK-733 (Simvastatin), a potent inhibitor of HMG-CoA reductase, on hypercholesterolemia and… Expand
Is this relevant?
Review
1988
Review
1988
Lovastatin (MK-803, mevinolin) and simvastatin (MK-733, synvinolin), 2 highly potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG… Expand
Is this relevant?
1986
1986
Mevinolin (MK803), a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) (Ki, 30 X 10(-9) M… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
1982
1982
Mevinolin (MK-803) is a potent inhibitor of HMG-CoA reductase. After a placebo run-in period, mevinolin 5,15 or 50 mg, or placebo… Expand
Is this relevant?